Table 2 Position and consequence of non-synonymous sequence changes identified in iAMP21-ALL patients with and without 12q CN-LOH and/or deletion of the SH2B3 region
Patient ID | 12q CN-LOH | SH2B3Ā CN | Somatically acquired variants | Germ line variants | |||
---|---|---|---|---|---|---|---|
Nucleotide sequence change | Protein sequence change | Level | p.R262W AF C/T | Other variant (AF) | |||
28 | Yes | 0 | ā | Ā | Ā | 100/0% | Ā |
25 | Yes | 2 | c.1174Cā>āT | p.R392Wa | 49% | 74/26% | Ā |
78 | Yes | 0b | Ā | Ā | Ā | 93/7% | Ā |
44 | Yes | 2 | c.1566dupC | p.E523Rfs | 63% | 100/0% | p.G451S (16%) |
45 | Yes | 2 | Ā | Ā | Ā | 0/100% | Ā |
88 | Yes | 2 | c.1198_1199insCT | p.E400Afs | 69% | 12/88% | Ā |
12 | Yes | 0 | ā | Ā | Ā | 100/0% | Ā |
3 | No | 0 | ā | Ā | Ā | 49/51% | Ā |
61 | No | 1 | c.760Tā>āG | p.C254G | 52% | 0/100% | Ā |
61 | No | 1 | c.763_773del | p.SSIQ255-258Gfs | 50% | Ā | Ā |
61 | No | 1 | c.775_776delGA_insCG | p.E259R | 51% | Ā | Ā |
19 | No | 2 | ā | Ā | Ā | 100/0% | Ā |
75 | No | 2 | ā | Ā | Ā | 100/0% | Ā |
77 | No | 2 | ā | Ā | Ā | 100/0% | Ā |
81 | No | 2 | ā | Ā | Ā | 100/0% | Ā |
84 | No | 2 | ā | Ā | Ā | 0/100% | Ā |
76 | No | 2 | ā | Ā | Ā | 0/100% | Ā |